"Pseudolymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed)
- Lymphoid Hyperplasia, Reactive
- Hyperplasia, Reactive Lymphoid
- Hyperplasias, Reactive Lymphoid
- Lymphoid Hyperplasias, Reactive
- Reactive Lymphoid Hyperplasia
- Reactive Lymphoid Hyperplasias
Below are MeSH descriptors whose meaning is more general than "Pseudolymphoma".
Below are MeSH descriptors whose meaning is more specific than "Pseudolymphoma".
This graph shows the total number of publications written about "Pseudolymphoma" by people in this website by year, and whether "Pseudolymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Pseudolymphoma" by people in Profiles.
Kailas A, Elston DM, Crater SE, Cerruto CA. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma. J Cutan Pathol. 2018 Apr; 45(4):296-298.
Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjögren syndrome. Clin Chest Med. 2010 Sep; 31(3):489-500.
Taylor RB, Fortney JA, Pollack RB, Metcalf JS, Jenrette JM. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol. 2010 Jun; 28(5):385-7.
Carrasco D, Cheng J, Lewin A, Warr G, Yang H, Rizzo C, Rosas F, Snapper C, Bravo R. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J Exp Med. 1998 Apr 06; 187(7):973-84.